Industry Research Reports
Part 1
Part 2
Part 3
Part 5
Home > Reports >
Pharma & Healthcare
>
Global and United States Gastrointestinal Stromal Tumor Drug Market Report & Forecast 2024-2030
Global and United States Gastrointestinal Stromal Tumor Drug Market Report & Forecast 2024-2030
-
Description
- Table of Contents
- Table of Figures
- PDF Download
-
Description
- Table of Contents
- Table of Figures
- PDF Download
The global Gastrointestinal Stromal Tumor Drug revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030). In United States the Gastrointestinal Stromal Tumor Drug revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Gastrointestinal Stromal Tumor Drug market, also covers the segmentation data of other regions in regional level and county level. The global key players of Gastrointestinal Stromal Tumor Drug include Novartis, Bayer Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., Apotex Inc., Mylan Pharms Inc., Bulat Pharmaceutical, etc. The global five biggest players hold a share of % in 2023. Gastrointestinal Stromal Tumor Drug market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Gastrointestinal Stromal Tumor Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030. For United States market, this report focuses on the Gastrointestinal Stromal Tumor Drug market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States. Market Segmentation
Report Metric
Details
Report Title
Global and United States Gastrointestinal Stromal Tumor Drug Market Report & Forecast 2024-2030
Global Gastrointestinal Stromal Tumor Drug Companies Covered
Novartis, Bayer Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., Apotex Inc., Mylan Pharms Inc., Bulat Pharmaceutical, MSN Laboratories, Vannsh Life Sciences, Beacon Pharmaceuticals, Drug International, Deciphera Pharmaceuticals, CSPC Pharmaceuticals, Hansoh Pharmaceuticals, Kelun Pharmaceuticals, Zai Lab, CStone Pharmaceuticals, China Biopharmaceuticals
Global Gastrointestinal Stromal Tumor Drug Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gastrointestinal Stromal Tumor Drug Market, Segment by Type
Imatinib
Sunitinib
Regorafenib
Ripretinib
Others
Global Gastrointestinal Stromal Tumor Drug Market, Segment by Application
Hospital
Clinic
Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline Chapter 1: Introduces Gastrointestinal Stromal Tumor Drug definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 4: Detailed analysis of Gastrointestinal Stromal Tumor Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 5: Revenue and volume of Gastrointestinal Stromal Tumor Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment. Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment. Chapter 8: China by Type, and by Application, sales, and revenue for each segment. Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment. Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Stromal Tumor Drug sales, revenue, gross margin, and recent development, etc. Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers. Chapter 12: research findings and conclusion
1 Study Coverage
1.1 Gastrointestinal Stromal Tumor Drug Product Introduction
1.2 Global Gastrointestinal Stromal Tumor Drug Outlook 2019 VS 2023 VS 2030
1.2.1 Global Gastrointestinal Stromal Tumor Drug Sales in US$ Million for the Year 2019-2030
1.2.2 Global Gastrointestinal Stromal Tumor Drug Sales in Volume for the Year 2019-2030
1.3 United States Gastrointestinal Stromal Tumor Drug Outlook 2019 VS 2023 VS 2030
1.3.1 United States Gastrointestinal Stromal Tumor Drug Sales in US$ Million for the Year 2019-2030
1.3.2 United States Gastrointestinal Stromal Tumor Drug Sales in Volume for the Year 2019-2030
1.4 Gastrointestinal Stromal Tumor Drug Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of United States Gastrointestinal Stromal Tumor Drug in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Gastrointestinal Stromal Tumor Drug Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.5 Gastrointestinal Stromal Tumor Drug Market Dynamics
1.5.1 Gastrointestinal Stromal Tumor Drug Industry Trends
1.5.2 Gastrointestinal Stromal Tumor Drug Market Drivers
1.5.3 Gastrointestinal Stromal Tumor Drug Market Challenges
1.5.4 Gastrointestinal Stromal Tumor Drug Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2.1 Gastrointestinal Stromal Tumor Drug Market by Type
2.1.1 Imatinib
2.1.2 Sunitinib
2.1.3 Regorafenib
2.1.4 Ripretinib
2.1.5 Others
2.2 Global Gastrointestinal Stromal Tumor Drug Market Size by Type
2.2.1 Global Gastrointestinal Stromal Tumor Drug Sales in Value, by Type (2019, 2023 & 2030)
2.2.2 Global Gastrointestinal Stromal Tumor Drug Sales in Volume, by Type (2019, 2023 & 2030)
2.2.3 Global Gastrointestinal Stromal Tumor Drug Average Selling Price (ASP) by Type (2019, 2023 & 2030)
2.3 United States Gastrointestinal Stromal Tumor Drug Market Size by Type
2.3.1 United States Gastrointestinal Stromal Tumor Drug Sales in Value, by Type (2019, 2023 & 2030)
2.3.2 United States Gastrointestinal Stromal Tumor Drug Sales in Volume, by Type (2019, 2023 & 2030)
2.3.3 United States Gastrointestinal Stromal Tumor Drug Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3.1 Gastrointestinal Stromal Tumor Drug Market by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Gastrointestinal Stromal Tumor Drug Market Size by Application
3.2.1 Global Gastrointestinal Stromal Tumor Drug Sales in Value, by Application (2019, 2023 & 2030)
3.2.2 Global Gastrointestinal Stromal Tumor Drug Sales in Volume, by Application (2019, 2023 & 2030)
3.2.3 Global Gastrointestinal Stromal Tumor Drug Average Selling Price (ASP) by Application (2019, 2023 & 2030)
3.3 United States Gastrointestinal Stromal Tumor Drug Market Size by Application
3.3.1 United States Gastrointestinal Stromal Tumor Drug Sales in Value, by Application (2019, 2023 & 2030)
3.3.2 United States Gastrointestinal Stromal Tumor Drug Sales in Volume, by Application (2019, 2023 & 2030)
3.3.3 United States Gastrointestinal Stromal Tumor Drug Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4.1 Global Gastrointestinal Stromal Tumor Drug Market Size by Company
4.1.1 Global Key Manufacturers of Gastrointestinal Stromal Tumor Drug, Ranked by Revenue (2023)
4.1.2 Global Gastrointestinal Stromal Tumor Drug Revenue by Manufacturer (2019-2024)
4.1.3 Global Gastrointestinal Stromal Tumor Drug Sales by Manufacturer (2019-2024)
4.1.4 Global Gastrointestinal Stromal Tumor Drug Price by Manufacturer (2019-2024)
4.2 Global Gastrointestinal Stromal Tumor Drug Concentration Ratio (CR)
4.2.1 Gastrointestinal Stromal Tumor Drug Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Gastrointestinal Stromal Tumor Drug in 2023
4.2.3 Global Gastrointestinal Stromal Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Gastrointestinal Stromal Tumor Drug, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Gastrointestinal Stromal Tumor Drug, Product Offered and Application
4.5 Global Key Manufacturers of Gastrointestinal Stromal Tumor Drug, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Gastrointestinal Stromal Tumor Drug Market Size by Company
4.7.1 Key Players of Gastrointestinal Stromal Tumor Drug in United States, Ranked by Revenue (2023)
4.7.2 United States Gastrointestinal Stromal Tumor Drug Revenue by Players (2019-2024)
4.7.3 United States Gastrointestinal Stromal Tumor Drug Sales by Players (2019-2024)
5.1 Global Gastrointestinal Stromal Tumor Drug Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Gastrointestinal Stromal Tumor Drug Market Size in Volume by Region (2019-2030)
5.2.1 Global Gastrointestinal Stromal Tumor Drug Sales in Volume by Region: 2019-2024
5.2.2 Global Gastrointestinal Stromal Tumor Drug Sales in Volume Forecast by Region (2025-2030)
5.3 Global Gastrointestinal Stromal Tumor Drug Market Size in Value by Region (2019-2030)
5.3.1 Global Gastrointestinal Stromal Tumor Drug Sales in Value by Region: 2019-2024
5.3.2 Global Gastrointestinal Stromal Tumor Drug Sales in Value by Region: 2025-2030
6.1 Americas Gastrointestinal Stromal Tumor Drug Market Size YoY Growth 2019-2030
6.2 Americas Gastrointestinal Stromal Tumor Drug Sales in Volume, by Type (2019, 2023 & 2030)
6.3 Americas Gastrointestinal Stromal Tumor Drug Sales in Volume, by Application (2019, 2023 & 2030)
6.4 Americas Gastrointestinal Stromal Tumor Drug Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 Americas Gastrointestinal Stromal Tumor Drug Sales in Value by Country (2019, 2023 & 2030)
6.4.2 Americas Gastrointestinal Stromal Tumor Drug Sales in Volume by Country (2019, 2023 & 2030)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7.1 EMEA Gastrointestinal Stromal Tumor Drug Market Size YoY Growth 2019-2030
7.2 EMEA Gastrointestinal Stromal Tumor Drug Sales in Volume, by Type (2019, 2023 & 2030)
7.3 EMEA Gastrointestinal Stromal Tumor Drug Sales in Volume, by Application (2019, 2023 & 2030)
7.4 EMEA Gastrointestinal Stromal Tumor Drug Market Facts & Figures by Country (2019, 2023 & 2030)
7.4.1 EMEA Gastrointestinal Stromal Tumor Drug Sales in Value by Country (2019, 2023 & 2030)
7.4.2 EMEA Gastrointestinal Stromal Tumor Drug Sales in Volume by Country (2019, 2023 & 2030)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8.1 China Gastrointestinal Stromal Tumor Drug Market Size YoY Growth 2019-2030
8.2 China Gastrointestinal Stromal Tumor Drug Sales in Volume, by Type (2019, 2023 & 2030)
8.3 China Gastrointestinal Stromal Tumor Drug Sales in Volume, by Application (2019, 2023 & 2030)
9.1 APAC Gastrointestinal Stromal Tumor Drug Market Size YoY Growth 2019-2030
9.2 APAC Gastrointestinal Stromal Tumor Drug Sales in Volume, by Type (2019, 2023 & 2030)
9.3 APAC Gastrointestinal Stromal Tumor Drug Sales in Volume, by Application (2019, 2023 & 2030)
9.4 APAC Gastrointestinal Stromal Tumor Drug Market Facts & Figures by Country (2019, 2023 & 2030)
9.4.1 APAC Gastrointestinal Stromal Tumor Drug Sales in Value by Country (2019, 2023 & 2030)
9.4.2 APAC Gastrointestinal Stromal Tumor Drug Sales in Volume by Country (2019, 2023 & 2030)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Description and Business Overview
10.1.3 Novartis Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.1.4 Novartis Gastrointestinal Stromal Tumor Drug Products Offered
10.1.5 Novartis Recent Development
10.2 Bayer Pharmaceuticals
10.2.1 Bayer Pharmaceuticals Company Information
10.2.2 Bayer Pharmaceuticals Description and Business Overview
10.2.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.2.4 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Products Offered
10.2.5 Bayer Pharmaceuticals Recent Development
10.3 Glenmark Pharmaceuticals Ltd.
10.3.1 Glenmark Pharmaceuticals Ltd. Company Information
10.3.2 Glenmark Pharmaceuticals Ltd. Description and Business Overview
10.3.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.3.4 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Products Offered
10.3.5 Glenmark Pharmaceuticals Ltd. Recent Development
10.4 Sun Pharmaceuticals
10.4.1 Sun Pharmaceuticals Company Information
10.4.2 Sun Pharmaceuticals Description and Business Overview
10.4.3 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.4.4 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Products Offered
10.4.5 Sun Pharmaceuticals Recent Development
10.5 Actavis Generics
10.5.1 Actavis Generics Company Information
10.5.2 Actavis Generics Description and Business Overview
10.5.3 Actavis Generics Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.5.4 Actavis Generics Gastrointestinal Stromal Tumor Drug Products Offered
10.5.5 Actavis Generics Recent Development
10.6 Dr. Reddy's Laboratories
10.6.1 Dr. Reddy's Laboratories Company Information
10.6.2 Dr. Reddy's Laboratories Description and Business Overview
10.6.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.6.4 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Products Offered
10.6.5 Dr. Reddy's Laboratories Recent Development
10.7 Teva Pharmaceutical Industries Ltd.
10.7.1 Teva Pharmaceutical Industries Ltd. Company Information
10.7.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
10.7.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.7.4 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Products Offered
10.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
10.8 Apotex Inc.
10.8.1 Apotex Inc. Company Information
10.8.2 Apotex Inc. Description and Business Overview
10.8.3 Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.8.4 Apotex Inc. Gastrointestinal Stromal Tumor Drug Products Offered
10.8.5 Apotex Inc. Recent Development
10.9 Mylan Pharms Inc.
10.9.1 Mylan Pharms Inc. Company Information
10.9.2 Mylan Pharms Inc. Description and Business Overview
10.9.3 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.9.4 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Products Offered
10.9.5 Mylan Pharms Inc. Recent Development
10.10 Bulat Pharmaceutical
10.10.1 Bulat Pharmaceutical Company Information
10.10.2 Bulat Pharmaceutical Description and Business Overview
10.10.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.10.4 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Products Offered
10.10.5 Bulat Pharmaceutical Recent Development
10.11 MSN Laboratories
10.11.1 MSN Laboratories Company Information
10.11.2 MSN Laboratories Description and Business Overview
10.11.3 MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.11.4 MSN Laboratories Gastrointestinal Stromal Tumor Drug Products Offered
10.11.5 MSN Laboratories Recent Development
10.12 Vannsh Life Sciences
10.12.1 Vannsh Life Sciences Company Information
10.12.2 Vannsh Life Sciences Description and Business Overview
10.12.3 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.12.4 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Products Offered
10.12.5 Vannsh Life Sciences Recent Development
10.13 Beacon Pharmaceuticals
10.13.1 Beacon Pharmaceuticals Company Information
10.13.2 Beacon Pharmaceuticals Description and Business Overview
10.13.3 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.13.4 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Products Offered
10.13.5 Beacon Pharmaceuticals Recent Development
10.14 Drug International
10.14.1 Drug International Company Information
10.14.2 Drug International Description and Business Overview
10.14.3 Drug International Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.14.4 Drug International Gastrointestinal Stromal Tumor Drug Products Offered
10.14.5 Drug International Recent Development
10.15 Deciphera Pharmaceuticals
10.15.1 Deciphera Pharmaceuticals Company Information
10.15.2 Deciphera Pharmaceuticals Description and Business Overview
10.15.3 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.15.4 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Products Offered
10.15.5 Deciphera Pharmaceuticals Recent Development
10.16 CSPC Pharmaceuticals
10.16.1 CSPC Pharmaceuticals Company Information
10.16.2 CSPC Pharmaceuticals Description and Business Overview
10.16.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.16.4 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Products Offered
10.16.5 CSPC Pharmaceuticals Recent Development
10.17 Hansoh Pharmaceuticals
10.17.1 Hansoh Pharmaceuticals Company Information
10.17.2 Hansoh Pharmaceuticals Description and Business Overview
10.17.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.17.4 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Products Offered
10.17.5 Hansoh Pharmaceuticals Recent Development
10.18 Kelun Pharmaceuticals
10.18.1 Kelun Pharmaceuticals Company Information
10.18.2 Kelun Pharmaceuticals Description and Business Overview
10.18.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.18.4 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Products Offered
10.18.5 Kelun Pharmaceuticals Recent Development
10.19 Zai Lab
10.19.1 Zai Lab Company Information
10.19.2 Zai Lab Description and Business Overview
10.19.3 Zai Lab Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.19.4 Zai Lab Gastrointestinal Stromal Tumor Drug Products Offered
10.19.5 Zai Lab Recent Development
10.20 CStone Pharmaceuticals
10.20.1 CStone Pharmaceuticals Company Information
10.20.2 CStone Pharmaceuticals Description and Business Overview
10.20.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.20.4 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Products Offered
10.20.5 CStone Pharmaceuticals Recent Development
10.21 China Biopharmaceuticals
10.21.1 China Biopharmaceuticals Company Information
10.21.2 China Biopharmaceuticals Description and Business Overview
10.21.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales, Revenue and Gross Margin (2019-2024)
10.21.4 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Products Offered
10.21.5 China Biopharmaceuticals Recent Development
11.1 Gastrointestinal Stromal Tumor Drug Industry Chain Analysis
11.2 Gastrointestinal Stromal Tumor Drug Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Gastrointestinal Stromal Tumor Drug Production Mode & Process
11.4 Gastrointestinal Stromal Tumor Drug Sales and Marketing
11.4.1 Gastrointestinal Stromal Tumor Drug Sales Channels
11.4.2 Gastrointestinal Stromal Tumor Drug Distributors
11.5 Gastrointestinal Stromal Tumor Drug Customers
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables Table 1. Gastrointestinal Stromal Tumor Drug CAGR in Value, United States VS Global, 2019 VS 2023 VS 2030 Table 2. Gastrointestinal Stromal Tumor Drug Market Trends Table 3. Gastrointestinal Stromal Tumor Drug Market Drivers Table 4. Gastrointestinal Stromal Tumor Drug Market Challenges Table 5. Gastrointestinal Stromal Tumor Drug Market Restraints Table 6. Global Gastrointestinal Stromal Tumor Drug Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million) Table 7. United States Gastrointestinal Stromal Tumor Drug Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million) Table 8. Global Gastrointestinal Stromal Tumor Drug Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million) Table 9. United States Gastrointestinal Stromal Tumor Drug Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million) Table 10. Global Key Manufacturers of Gastrointestinal Stromal Tumor Drug, Ranked by Revenue (2023) & (US$ Million) Table 11. Global Gastrointestinal Stromal Tumor Drug Revenue by Manufacturer, (US$ Million) & (2019-2024) Table 12. Global Gastrointestinal Stromal Tumor Drug Revenue Share by Manufacturer, 2019-2024 Table 13. Global Gastrointestinal Stromal Tumor Drug Sales by Manufacturer, (K Units), 2019-2024 Table 14. Global Gastrointestinal Stromal Tumor Drug Sales Share by Manufacturer, 2019-2024 Table 15. Global Gastrointestinal Stromal Tumor Drug Price by Manufacturer (2019-2024) & (US$/Unit) Table 16. Global Gastrointestinal Stromal Tumor Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Gastrointestinal Stromal Tumor Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Drug as of 2023) Table 18. Global Key Manufacturers of Gastrointestinal Stromal Tumor Drug, Manufacturing Base Distribution and Headquarters Table 19. Global Key Manufacturers of Gastrointestinal Stromal Tumor Drug, Product Offered and Application Table 20. Global Key Manufacturers of Gastrointestinal Stromal Tumor Drug, Date of Enter into This Industry Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Key Players of Gastrointestinal Stromal Tumor Drug in United States, Ranked by Revenue (2023) & (US$ million) Table 23. United States Gastrointestinal Stromal Tumor Drug Revenue by Players, (US$ Million) & (2019-2024) Table 24. United States Gastrointestinal Stromal Tumor Drug Revenue Share by Players, (2019-2024) Table 25. United States Gastrointestinal Stromal Tumor Drug Sales by Players, (K Units) & (2019-2024) Table 26. United States Gastrointestinal Stromal Tumor Drug Sales Share by Players, (2019-2024) Table 27. Global Gastrointestinal Stromal Tumor Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 28. Global Gastrointestinal Stromal Tumor Drug Sales in Volume by Region (2019-2024) & (K Units) Table 29. Global Gastrointestinal Stromal Tumor Drug Sales in Volume Forecast by Region (2025-2030) & (K Units) Table 30. Global Gastrointestinal Stromal Tumor Drug Sales in Value by Region (2019-2024) & (US$ Million) Table 31. Global Gastrointestinal Stromal Tumor Drug Sales in Value Forecast by Region (2025-2030) & (US$ Million) Table 32. Americas Gastrointestinal Stromal Tumor Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 33. Americas Gastrointestinal Stromal Tumor Drug Sales in Value by Country (2019-2024) & (US$ Million) Table 34. Americas Gastrointestinal Stromal Tumor Drug Sales in Value by Country (2025-2030) & (US$ Million) Table 35. Americas Gastrointestinal Stromal Tumor Drug Sales in Volume by Country (2019-2024) & (K Units) Table 36. Americas Gastrointestinal Stromal Tumor Drug Sales in Volume by Country (2025-2030) & (K Units) Table 37. EMEA Gastrointestinal Stromal Tumor Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 38. EMEA Gastrointestinal Stromal Tumor Drug Sales in Value by Country (2019-2024) & (US$ Million) Table 39. EMEA Gastrointestinal Stromal Tumor Drug Sales in Value by Country (2025-2030) & (US$ Million) Table 40. EMEA Gastrointestinal Stromal Tumor Drug Sales in Volume by Country (2019-2024) & (K Units) Table 41. EMEA Gastrointestinal Stromal Tumor Drug Sales in Volume by Country (2025-2030) & (K Units) Table 42. APAC Gastrointestinal Stromal Tumor Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 43. APAC Gastrointestinal Stromal Tumor Drug Sales in Value by Country (2019-2024) & (US$ Million) Table 44. APAC Gastrointestinal Stromal Tumor Drug Sales in Value by Country (2025-2030) & (US$ Million) Table 45. APAC Gastrointestinal Stromal Tumor Drug Sales in Volume by Country (2019-2024) & (K Units) Table 46. APAC Gastrointestinal Stromal Tumor Drug Sales in Volume by Country (2025-2030) & (K Units) Table 47. Novartis Company Information Table 48. Novartis Description and Business Overview Table 49. Novartis Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 50. Novartis Gastrointestinal Stromal Tumor Drug Product Table 51. Novartis Recent Development Table 52. Bayer Pharmaceuticals Company Information Table 53. Bayer Pharmaceuticals Description and Business Overview Table 54. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 55. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Table 56. Bayer Pharmaceuticals Recent Development Table 57. Glenmark Pharmaceuticals Ltd. Company Information Table 58. Glenmark Pharmaceuticals Ltd. Description and Business Overview Table 59. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 60. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product Table 61. Glenmark Pharmaceuticals Ltd. Recent Development Table 62. Sun Pharmaceuticals Company Information Table 63. Sun Pharmaceuticals Description and Business Overview Table 64. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 65. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Table 66. Sun Pharmaceuticals Recent Development Table 67. Actavis Generics Company Information Table 68. Actavis Generics Description and Business Overview Table 69. Actavis Generics Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 70. Actavis Generics Gastrointestinal Stromal Tumor Drug Product Table 71. Actavis Generics Recent Development Table 72. Dr. Reddy's Laboratories Company Information Table 73. Dr. Reddy's Laboratories Description and Business Overview Table 74. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 75. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product Table 76. Dr. Reddy's Laboratories Recent Development Table 77. Teva Pharmaceutical Industries Ltd. Company Information Table 78. Teva Pharmaceutical Industries Ltd. Description and Business Overview Table 79. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 80. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product Table 81. Teva Pharmaceutical Industries Ltd. Recent Development Table 82. Apotex Inc. Company Information Table 83. Apotex Inc. Description and Business Overview Table 84. Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 85. Apotex Inc. Gastrointestinal Stromal Tumor Drug Product Table 86. Apotex Inc. Recent Development Table 87. Mylan Pharms Inc. Company Information Table 88. Mylan Pharms Inc. Description and Business Overview Table 89. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 90. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product Table 91. Mylan Pharms Inc. Recent Development Table 92. Bulat Pharmaceutical Company Information Table 93. Bulat Pharmaceutical Description and Business Overview Table 94. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 95. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product Table 96. Bulat Pharmaceutical Recent Development Table 97. MSN Laboratories Company Information Table 98. MSN Laboratories Description and Business Overview Table 99. MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 100. MSN Laboratories Gastrointestinal Stromal Tumor Drug Product Table 101. MSN Laboratories Recent Development Table 102. Vannsh Life Sciences Company Information Table 103. Vannsh Life Sciences Description and Business Overview Table 104. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 105. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product Table 106. Vannsh Life Sciences Recent Development Table 107. Beacon Pharmaceuticals Company Information Table 108. Beacon Pharmaceuticals Description and Business Overview Table 109. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 110. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Table 111. Beacon Pharmaceuticals Recent Development Table 112. Drug International Company Information Table 113. Drug International Description and Business Overview Table 114. Drug International Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 115. Drug International Gastrointestinal Stromal Tumor Drug Product Table 116. Drug International Recent Development Table 117. Deciphera Pharmaceuticals Company Information Table 118. Deciphera Pharmaceuticals Description and Business Overview Table 119. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 120. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Table 121. Deciphera Pharmaceuticals Recent Development Table 122. CSPC Pharmaceuticals Company Information Table 123. CSPC Pharmaceuticals Description and Business Overview Table 124. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 125. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Table 126. CSPC Pharmaceuticals Recent Development Table 127. Hansoh Pharmaceuticals Company Information Table 128. Hansoh Pharmaceuticals Description and Business Overview Table 129. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 130. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Table 131. Hansoh Pharmaceuticals Recent Development Table 132. Kelun Pharmaceuticals Company Information Table 133. Kelun Pharmaceuticals Description and Business Overview Table 134. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 135. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Table 136. Kelun Pharmaceuticals Recent Development Table 137. Zai Lab Company Information Table 138. Zai Lab Description and Business Overview Table 139. Zai Lab Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 140. Zai Lab Gastrointestinal Stromal Tumor Drug Product Table 141. Zai Lab Recent Development Table 142. CStone Pharmaceuticals Company Information Table 143. CStone Pharmaceuticals Description and Business Overview Table 144. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 145. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product Table 146. CStone Pharmaceuticals Recent Development Table 147. China Biopharmaceuticals Company Information Table 148. China Biopharmaceuticals Description and Business Overview Table 149. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 150. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product Table 151. China Biopharmaceuticals Recent Development Table 152. Key Raw Materials Lists Table 153. Raw Materials Key Suppliers Lists Table 154. Gastrointestinal Stromal Tumor Drug Distributors List Table 155. Gastrointestinal Stromal Tumor Drug Customers List Table 156. Research Programs/Design for This Report Table 157. Key Data Information from Secondary Sources Table 158. Key Data Information from Primary Sources List of Figures Figure 1. Gastrointestinal Stromal Tumor Drug Product Picture Figure 2. Global Gastrointestinal Stromal Tumor Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030 Figure 3. Global Gastrointestinal Stromal Tumor Drug Market Size 2019-2030 (US$ Million) Figure 4. Global Gastrointestinal Stromal Tumor Drug Sales 2019-2030 (K Units) Figure 5. United States Gastrointestinal Stromal Tumor Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030 Figure 6. United States Gastrointestinal Stromal Tumor Drug Market Size 2019-2030 (US$ Million) Figure 7. United States Gastrointestinal Stromal Tumor Drug Sales 2019-2030 (K Units) Figure 8. United States Gastrointestinal Stromal Tumor Drug Market Share in Global, in Value (US$ Million) 2019-2030 Figure 9. United States Gastrointestinal Stromal Tumor Drug Market Share in Global, in Volume (K Units) 2019-2030 Figure 10. Gastrointestinal Stromal Tumor Drug Report Years Considered Figure 11. Product Picture of Imatinib Figure 12. Product Picture of Sunitinib Figure 13. Product Picture of Regorafenib Figure 14. Product Picture of Ripretinib Figure 15. Product Picture of Others Figure 16. Global Gastrointestinal Stromal Tumor Drug Market Share by Type in 2023 & 2030 Figure 17. Global Gastrointestinal Stromal Tumor Drug Sales in Value by Type (2019-2030) & (US$ Million) Figure 18. Global Gastrointestinal Stromal Tumor Drug Sales Market Share in Value by Type (2019-2030) Figure 19. Global Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2030) & (K Units) Figure 20. Global Gastrointestinal Stromal Tumor Drug Sales Market Share in Volume by Type (2019-2030) Figure 21. Global Gastrointestinal Stromal Tumor Drug Price by Type (2019-2030) & (US$/Unit) Figure 22. United States Gastrointestinal Stromal Tumor Drug Market Share by Type in 2023 & 2030 Figure 23. United States Gastrointestinal Stromal Tumor Drug Sales in Value by Type (2019-2030) & (US$ Million) Figure 24. United States Gastrointestinal Stromal Tumor Drug Sales Market Share in Value by Type (2019-2030) Figure 25. United States Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2030) & (K Units) Figure 26. United States Gastrointestinal Stromal Tumor Drug Sales Market Share in Volume by Type (2019-2030) Figure 27. United States Gastrointestinal Stromal Tumor Drug Price by Type (2019-2030) & (US$/Unit) Figure 28. Product Picture of Hospital Figure 29. Product Picture of Clinic Figure 30. Product Picture of Others Figure 31. Global Gastrointestinal Stromal Tumor Drug Market Share by Application in 2023 & 2030 Figure 32. Global Gastrointestinal Stromal Tumor Drug Sales in Value by Application (2019-2030) & (US$ Million) Figure 33. Global Gastrointestinal Stromal Tumor Drug Sales Market Share in Value by Application (2019-2030) Figure 34. Global Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2030) & (K Units) Figure 35. Global Gastrointestinal Stromal Tumor Drug Sales Market Share in Volume by Application (2019-2030) Figure 36. Global Gastrointestinal Stromal Tumor Drug Price by Application (2019-2030) & (US$/Unit) Figure 37. United States Gastrointestinal Stromal Tumor Drug Market Share by Application in 2023 & 2030 Figure 38. United States Gastrointestinal Stromal Tumor Drug Sales in Value by Application (2019-2030) & (US$ Million) Figure 39. United States Gastrointestinal Stromal Tumor Drug Sales Market Share in Value by Application (2019-2030) Figure 40. United States Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2030) & (K Units) Figure 41. United States Gastrointestinal Stromal Tumor Drug Sales Market Share in Volume by Application (2019-2030) Figure 42. United States Gastrointestinal Stromal Tumor Drug Price by Application (2019-2030) & (US$/Unit) Figure 43. The Top 5 and 10 Largest Manufacturers of Gastrointestinal Stromal Tumor Drug in the World: Market Share by Gastrointestinal Stromal Tumor Drug Revenue in 2023 Figure 44. Global Gastrointestinal Stromal Tumor Drug Market Size Market Share by Region: 2019 VS 2023 VS 2030 Figure 45. Global Gastrointestinal Stromal Tumor Drug Sales in Volume Market Share by Region (2019-2030) Figure 46. Global Gastrointestinal Stromal Tumor Drug Sales in Value Market Share by Region (2019-2030) Figure 47. Americas Gastrointestinal Stromal Tumor Drug Sales in Volume Growth Rate 2019-2030 (K Units) Figure 48. Americas Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate 2019-2030 (US$ Million) Figure 49. Americas Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2030) & (K Units) Figure 50. Americas Gastrointestinal Stromal Tumor Drug Sales Market Share in Volume by Type (2019-2030) Figure 51. Americas Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2030) & (K Units) Figure 52. Americas Gastrointestinal Stromal Tumor Drug Sales Market Share in Volume by Application (2019-2030) Figure 53. United States Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate (2019-2030) & (US$ Million) Figure 54. Canada Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate (2019-2030) & (US$ Million) Figure 55. Mexico Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate (2019-2030) & (US$ Million) Figure 56. Brazil Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate (2019-2030) & (US$ Million) Figure 57. EMEA Gastrointestinal Stromal Tumor Drug Sales in Volume Growth Rate 2019-2030 (K Units) Figure 58. EMEA Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate 2019-2030 (US$ Million) Figure 59. EMEA Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2030) & (K Units) Figure 60. EMEA Gastrointestinal Stromal Tumor Drug Sales Market Share in Volume by Type (2019-2030) Figure 61. EMEA Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2030) & (K Units) Figure 62. EMEA Gastrointestinal Stromal Tumor Drug Sales Market Share in Volume by Application (2019-2030) Figure 63. Europe Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate (2019-2030) & (US$ Million) Figure 64. Middle East Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate (2019-2030) & (US$ Million) Figure 65. Africa Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate (2019-2030) & (US$ Million) Figure 66. China Gastrointestinal Stromal Tumor Drug Sales in Volume Growth Rate 2019-2030 (K Units) Figure 67. China Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate 2019-2030 (US$ Million) Figure 68. China Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2030) & (K Units) Figure 69. China Gastrointestinal Stromal Tumor Drug Sales Market Share in Volume by Type (2019-2030) Figure 70. China Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2030) & (K Units) Figure 71. China Gastrointestinal Stromal Tumor Drug Sales Market Share in Volume by Application (2019-2030) Figure 72. APAC Gastrointestinal Stromal Tumor Drug Sales in Volume Growth Rate 2019-2030 (K Units) Figure 73. APAC Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate 2019-2030 (US$ Million) Figure 74. APAC Gastrointestinal Stromal Tumor Drug Sales by Type (2019-2030) & (K Units) Figure 75. APAC Gastrointestinal Stromal Tumor Drug Sales Market Share in Volume by Type (2019-2030) Figure 76. APAC Gastrointestinal Stromal Tumor Drug Sales by Application (2019-2030) & (K Units) Figure 77. APAC Gastrointestinal Stromal Tumor Drug Sales Market Share in Volume by Application (2019-2030) Figure 78. Japan Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate (2019-2030) & (US$ Million) Figure 79. South Korea Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate (2019-2030) & (US$ Million) Figure 80. China Taiwan Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate (2019-2030) & (US$ Million) Figure 81. Southeast Asia Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate (2019-2030) & (US$ Million) Figure 82. India Gastrointestinal Stromal Tumor Drug Sales in Value Growth Rate (2019-2030) & (US$ Million) Figure 83. Gastrointestinal Stromal Tumor Drug Value Chain Figure 84. Gastrointestinal Stromal Tumor Drug Production Process Figure 85. Channels of Distribution (Direct Vs Distribution) Figure 86. Bottom-up and Top-down Approaches for This Report Figure 87. Data Triangulation Figure 88. Key Executives Interviewed
The global Gastrointestinal Stromal Tumor Drug revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030). In United States the Gastrointestinal Stromal Tumor Drug revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Gastrointestinal Stromal Tumor Drug market, also covers the segmentation data of other regions in regional level and county level. The global key players of Gastrointestinal Stromal Tumor Drug include Novartis, Bayer Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., Apotex Inc., Mylan Pharms Inc., Bulat Pharmaceutical, etc. The global five biggest players hold a share of % in 2023. Gastrointestinal Stromal Tumor Drug market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Gastrointestinal Stromal Tumor Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030. For United States market, this report focuses on the Gastrointestinal Stromal Tumor Drug market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States. Market Segmentation
Chapter Outline Chapter 1: Introduces Gastrointestinal Stromal Tumor Drug definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 4: Detailed analysis of Gastrointestinal Stromal Tumor Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 5: Revenue and volume of Gastrointestinal Stromal Tumor Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment. Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment. Chapter 8: China by Type, and by Application, sales, and revenue for each segment. Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment. Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Stromal Tumor Drug sales, revenue, gross margin, and recent development, etc. Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers. Chapter 12: research findings and conclusion
CHOOSE LICENSE TYPE
USD 4350.00
USD 6525.00
USD 8700.00
Add to Cart
Buy Now
Have a question?
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
General Email:
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Have a question?
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
General Email:
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
-
Fastest report delivery service
-
More than 17 years of vast experience
-
Operation for 24 * 7 & 365 days
-
In-depth and comprehensive analysis
-
Professional and timely after-sales service
-
Owns large database
Add to Cart
Buy Now